Ignite Creation Date:
2024-05-06 @ 3:22 PM
Last Modification Date:
2024-10-26 @ 1:48 PM
Study NCT ID:
NCT04604028
Status:
UNKNOWN
Last Update Posted:
2020-10-27
First Post:
2020-09-21
Brief Title:
Lenalidomide and Low-dose Cyclophosphamide for MALT Lymphoma
Sponsor:
National Taiwan University Hospital
Organization:
National Taiwan University Hospital
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Refractory Extranodal Marginal Zone B-Cell Lymphoma MALT |
| Antibiotics-unresponsive MALT Lymphoma |
| Relapsed MALT Type Extranodal Marginal Zone B-Cell Lymphoma |